Melatonin decreases homocysteine level in blood of rats

Journal of Physiology and Pharmacology

Volumn 59, Issue 4, 2008, Pages 717-729

  Murawska Cialowicz, Eugenia ^a   Januszewska, L ^b   Zuwala Jagiello, J ^b   Milczarska, J ^c   Zawadzki, M ^b   Paprocka Borowicz, M ^b   Wierzbicka Damska, I ^a  

^a UNIVERSITY SCHOOL OF PHYSICAL EDUCATION   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

^c Heart Surgery Dept   (Poland)

Author keywords

Blood; Homocysteine; Lipid peroxidation; Melatonin; Nitric oxide; Rats

Indexed keywords

HOMOCYSTEINE; MALONALDEHYDE; MELATONIN; METHIONINE; NITROGEN DIOXIDE; NITROGEN OXIDE;

AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HYPERHOMOCYSTEINEMIA; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; RAT;

ALDEHYDES; ANIMALS; ANTIOXIDANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HOMOCYSTEINE; HUMANS; MALONDIALDEHYDE; MELATONIN; METHIONINE; NITRIC OXIDE; OXIDATIVE STRESS; RATS; RATS, WISTAR;

EID: 58449113612     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Magott M. Homocysteine non-lipid factor of arteriosclerosis. Adv Med Hyg Exp 1998; 52: 259-267.
2. Fu W, Dudman NP, Perry MA, Young K, Wang XL. Interrelations between plasma homocysteine and intracellular S-adenosylhomocysteine. Biochem Biophys Res Commun 2000; 29: 47-53.
3. House JD, Jacobs RL, Stead LM et al. Regulation of homocysteine metabolism. Adv Enzyme Regul 1999; 39: 69-91.
4. Stickel F, Choi SW, Kim YI et al. Effect of chronic alcohol consumption on total plasma homocysteine levels in rats. Alcohol Clin Exp Res 2000; 24: 259-264.
5. De Bree A, Verschuren WM, Blom HJE et al. Lifestyle factors and plasma homocysteine concentrations in a general population sample. Am J Epidemiol 2001; 15: 150-154.
6. Hankey GJ, Eikelboom JW. Homocysteine and vascular disease. Lancet 1999; 354: 407-413.
7. Prashad K. Homocysteine, a risk factor for cardiovascular disease. Int J Angiol 1999; 8: 76-86.
8. McCully KS. Growth disorders and homocysteine metabolism. Ann Clin Lab Sci 1975, 5: 147-152.
9. Nygard O, Nordrehaug JE, Refsum H et al. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997; 337: 230-236.
10. Harpel PC, Chang VT, Borth W. Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein (a) to fibrin: Apotential biochemical link between thrombosis, atherogenesis, and sulfhydryl compound metabolism. Proc Natl Acad Sci USA 1992 ; 89: 10193-10197.
11. Maxwell SRJ: Coronary artery disease-free radical damage, antioxidant protection and the role of homocysteine. Basic Res Cardiol 2000; 95; I/65-I/71.
12. Osuna C, Reiter RJ, Garcia JJ et al. Inhibitory effect of melatonin on homocysteine-induced lipid peroxidation in rat brain homogenats. Pharmacol Toxicol 2002; 90: 32-37.
13. Toborek M, Henning B: Dietary methionine imbalance, endothelial cell dysfunction and atherosclerosis. Nutr Res 1996; 16: 1251-1266.
14. Durand P, Lussier-Cacan S, Blanche D. Acute methionine load-induced hyperhomocysteinemia enhances platelet aggregation, thromboxane biosynthesis, and macrophage-derived tissue factor activity in rats. FASEB J 1997; 11: 1157-1168.
15. Aukrust P, Berge RK, Muller F, Ueland PM, Svardal AM, Froland SS. Elevated plasma levels of reduced homocysteine in common variable immunodeficiency- a marker of enhanced oxidative stress. Eur J Clin Invest 1997; 27: 723-730.
16. Huang RF, Hsu YC, Lin HL, Yang FL. Folate depletion and elevated plasma homocysteine promote oxidative stress in rat livers. J Nutr 2001; 131: 33-38.
17. Mujumdar VS, Aru GM, Tyagi SC. Induction of oxidative stress by homocyst(e)ine impairs endothelial function. J Cell Biochem 2001; 82: 491-500.
18. White CR, Brock TA, Chang L-Y et al. Superoxide and peroxynitrite in atherosclerosis. Proc Natl Acad Sci USA 1994; 91: 1044-1048.
19. Beyer CHE, Steketee JD, Saphier D. Antioxidant properties of melatonin - an emerging mystery. Biochem Pharmacol 1998; 56: 1265-1272.
20. Reiter JR: Functional aspects of the pineal hormone melatonin in combating cell and tissue damage induced by free radicals. Eur J Endocrinol 1996; 134: 412-420.
21. Von Gall CH, Stehle JH, Weaver DR. Mammalian melatonin receptors: molecular biology and signal transduction. Cell Tissue Res 2002; 309: 151-162.
22. Baydays G, Gursu MF, Cikim G et al. Effects of pinealectomy on the levels and the circadian rhythm of plasma homocysteine in rats. J Pineal Res 2002; 33: 151-155.
23. Karasek M. Winczyk K. Melatonin in humans. J Physiol Pharmacol 2006; 57: 19-39.
24. Leja-Szpak A, Jaworek J, Szklarczyk J, Konturek SJ, Pawlik W.W. Melatonin stimulates HSP27 phosphorylationin human pancreatic carcinoma cells (PANC-1). J Physiol Pharmacol 2007; 58; 177-188.
25. Konturek SJ, Konturek PC, Brzozowski T. Prostaglandins and ulcer healing. J Physiol Pharmacol 2005; 56: 5-31.
26. Konturek SJ, Konturek PC, Brzozowska I et al. Localization and biological activities of melatonin in intact and diseased gastrointestinal tract (GIT). J Physiol Pharmacol 2007; 58: 381-405.
27. Antunes F, Barclay CL, Igold CU et al. On the antioxidant ativity of melatonin. Free Radic Biol Med 1999; 26: 117-128.
28. Kashimoto S, Kume M, Ikeya K, Ishiyama T, Kumazawa T. Effects of melatonin and superoxide dismutase on free radical formation in the postischemic reperfused heart. J Anesth 1999; 13: 23-28.
29. Mayo JC, Sainz RM, Antolin I et al. Melatonin regulation of antioxidant enzyme gene expression. Cell Mol Life Sci 2002; 59: 1706-1713.
30. Reiter RJ, Tan D-X, Manchester MC, Qi W. Biochemical reactivity of melatonin with reactive oxygen and nitrogen species. Cell Biochem Biophys 2001; 34: 237-256.
31. Reiter JR, Maestroni GJM. Melatonin in relation to the antioxidative defense and immune systems : possible implications for cell and organ transplantation. J Mol Med 1999; 77: 36-39.
32. Rodriguez C, Mayo JC, Sainz RM et al. Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 2004; 36: 1-9.
33. Horstman JA, Wrona MZ, Dryhurst G. Further insights into the reaction of melatonin with hydroxyl radical. Bioorg Chem 2002; 30: 371-382.
34. Ueland PM, Refsum H. Plasma homocysteine, a risk factor for vascular disease - plasma levels in health, disease and drug therapy. J Lab Clin Med 1989; 114: 473-501.
35. Clarke R, Daly L, Robinson K et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 1991; 313: 709-715.
36. Stampfer MJ, Malinov MR: Can lowering homocysteine levels reduce cardiovascular risk? N Engl J Med 1995; 332: 328-329.
37. Verhoef P, Kok FJ, Kruyssen DA et al. Plasma total homocysteine, B vitamins, of coronary atherosclerosis. Arterioscler Thromb Vasc Biol 1997; 17: 989-995.
38. Chow K, Cheung F, Lao TTH: Effect of homocysteine on the production of nitric oxide in endothelial cells. Clin Exp Pharmacol Physiol 1999; 26: 817-818.
39. Perna AF, Ingrosso D, Lombardi C et al. Possible mechanisms of homocysteine toxicity. Kidney Int 2003; 63: S137-S140.
40. Schlaich MP, John S, Jacobi J, Lackner KJ, Schmieder R. Mildly elevated homocysteine concentrations impair endothelium dependent vasodilation in hypercholesterolemic patients. Atherosclerosis 2000; 153: 383-389.
41. Upchurch GR Jr, Welch GN, Fabian AJ, Piqazzi A, Keaney JF, Loscalzo J. Stimulation of endothelial nitric oxide production by homocyst(e)ine. Atherosclerosis 1997; 132: 177-185.
42. Upchurch GR Jr, Welch GN, Fabian AJ et al. Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J Biol Chem 1997; 272: 17012-17017.
43. Chao C, Kuo T, Lee Y. Effects of methionine-induced hyperhomocysteinemia on endothelium-dependent vasodilation and oxidative status in healthy adults. Circulation 2000; 101: 485-490.
44. Ungvari Z, Pacher P, Rishak K, Szollar L, Koller A. Dysfunction of nitric oxide mediation in isolated rat arterioles with methionine diet induced hyperhomocysteinemia. Arterioscler Thromb Vasc Biol 1999; 19: 1899-1904.
45. Ensley AM, Jeremy JY, Gomes GN, Angellini GD, Plane F. Investigation of the inhibitory effects of homocysteine and cooper on nitric oxide-mediate teraxation of rat isolated aota. Br J Pharmacol 1999, 26, 1034-1040.
46. Campolo J, De Chiara B, Caruso R et al. Methionine challenge paradoxically induces a greater activation of the antioxidant defence in subjects with hyper- vs. normohomocysteinemia. Free Radic Res 2006; 40: 929-935.
47. Romerio SC, Linder L, Nyfeler J et al. Acute hyperhomocysteinemia decreases NO bioavailability in healthy adults. Atherosclerossis 2004; 176: 337-344.
48. Okatani Y, Wakatsuka A, Reiter RJ. Protective effect of melatonin against homocysteine-induced vasoconstriction of human umbilical artery. Biochem Biophys Res Commun 2000; 277: 470-475.
49. Okatani Y, Watanabe K, Hayashi K et al. Melatonin inhibits vasospastic action of hydrogen peroxide in human umbilical artery. J Pineal Res 1997; 22: 163-168.
50. Jin L, Caldwell RB, Li-Masters T, Caldwell RW. Homocysteine induces endothelial dysfunction via inhibition of arginine transport. J Physiol Pharmacol 2007; 58: 191-206.
51. Mariotti F, Hammiche A, Blouet C, Dare S, Tome D, Huneau JF. Medium - term methionine supplementation increases plasma homocysteine but not ADMA and improves blood pressure control in rats fed a diet rich in protein and adequate in folate and choline. Eur J Nutr 2006; 45: 383-390.
52. Finkelstein JD, Martin JJ. Methionine metabolism in mammals. Adaptation to methionine excess. J Biol Chem 1986; 261:1582-1587.
53. Upchurch GR Jr, Welch GN, Freedman JF et al. Homocysteine attenuates endothelial glutathione peroxidase and thereby potentiates peroxide-mediated cell injury. Circulation 1995; 92: I-228.
54. Upchurch GR Jr, Welch GN, Ramdev N et al. The effect of homocysteine on endothelial cell nitric oxide production. FASEB 1995; 9: A876.
55. Freedman JF, Frei B, Welch GN, Loscalzo J. Glutathione peroxidase potentiates the inhibition of platelet function by S-nitrosothiols. J Clin Invest 1995; 96: 394-400.
56. Buczynski A, Wachowicz B, Kedziora - Kornatowska K et al. Changes in antioxidant enzymes activities, aggregability and malonyldialdehyde concentration in blood platelets from patients with coronary heart disease. Atherosclerosis 1993; 100: 223-228
57. Barlow-Walden LR, Reiter RJ, Abe M et al. Melatonin stimulates brain gluthatione peroxidase activity. Neurochem Int 1995; 26: 497-502.
58. Wakatsuki A, Okatani Y. Melatonin protects against the free radical - induced impairment of nitric oxide production in the human umbilical artery. J Pineal Res 2000; 28: 172-178.
59. Baydays G, Yilmaz O, Celik S et al. Effects of certain micronutrients and melatonin on plasma lipid, lipid peroxidation, and homocysteine levels in rats. Arch Med Res 2002; 33: 515-519.
60. Jaworek J, Nawrot-Porabka K, Leja-Szpak A et al. Melatonin as modulator of pancreatic enzyme secretion and pancreatoprotector. J Physiol Pharmacol 2007; 58: 65-80.